Evidence map›Paper›PMID 32866347›Full record

ArticleAmerican journal of medical genetics. Part C, Seminars in medical genetics2020

The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literature.

Malena Daich Varela, Priyam Jani, Wadih M Zein, Precilla D'Souza, Lynne Wolfe, Jennifer Chisholm, Christopher Zalewski, David Adams, Blake M Warner, Laryssa A Huryn and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part C, Seminars in medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Polyunsaturated fatty acid metabolism in the retinal pigment epithelium and its association with outer retinal disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ophthalmology science · 2021
    Article
  9. Article
  10. Review
  11. Introduction to the special issue on Ophthalmic Genetics: Vision in 2020.American journal of medical genetics. Part C, Seminars in medical genetics · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Malena Daich VarelaOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.ORCID 0000-0003-4960-4510
Priyam JaniNational Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA.
Wadih M ZeinOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Precilla D'SouzaOffice of the Clinical Director, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA.
Lynne WolfeUndiagnosed Diseases Program, Common Fund, NIH, Bethesda, Maryland, USA.
Jennifer ChisholmAudiology Unit, Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
Christopher ZalewskiAudiology Unit, Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
David AdamsOffice of the Clinical Director, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA.
Blake M WarnerNational Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA.
Laryssa A HurynOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Robert B HufnagelOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
National Institutes of Health · USNational Human Genome Research Institute · USNational Institute on Deafness and Other Communication Disorders · USOffice of the Director · US

Funding

Clinical Investigations of Sjogren's SyndromeZIADE000704 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI WARNER, BLAKE · 2009 to 2025
$22.3M
Genomic and epigenomic mechanisms of pediatric ocular disordersZIAEY000565 · NEI · NATIONAL EYE INSTITUTE · PI HUFNAGEL, ROBERT · 2019 to 2024
$11.4M
Ophthalmic Genetics FellowshipZIEEY000477 · NEI · NATIONAL EYE INSTITUTE · PI HURYN, LARYSSA · 2009 to 2025
$7.2M
NIDCR DIR Clinical TrainingZIEDE000727 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MAYS, JACQUELINE · 2009 to 2025
$6.8M
Intramural NIH HHS ZIA EY000565
6 · The paper itself

Abstract

The spectrum of peroxisomal disorders is wide and comprises individuals that die in the first year of life, as well as people with sensorineural hearing loss, retinal dystrophy and amelogenesis imperfecta. In this article, we describe three patients; two diagnosed with Heimler syndrome and a third one with a mild-intermediate phenotype. We arrived at these diagnoses by conducting complete ophthalmic (National Eye Institute), auditory (National Institute of Deafness and Other Communication Disorders), and dental (National Institute of Dental and Craniofacial Research) evaluations, as well as laboratory and genetic testing. Retinal degeneration with macular cystic changes, amelogenesis imperfecta, and sensorineural hearing loss were features shared by the three patients. Patients A and C had pathogenic variants in PEX1 and Patient B, in PEX6. Besides analyzing these cases, we review the literature regarding mild peroxisomal disorders, their pathophysiology, genetics, differential diagnosis, diagnostic methods, and management. We suggest that peroxisomal disorders are considered in every child with sensorineural hearing loss and retinal degeneration. These patients should have a dental evaluation to rule out amelogenesis imperfecta as well as audiologic examination and laboratory testing including peroxisomal biomarkers and genetic testing. Appropriate diagnosis can lead to better genetic counseling and management of the associated comorbidities.

Indexed as

AdolescentAdultAmelogenesis ImperfectaATPases Associated with Diverse Cellular ActivitiesChildFemaleGenetic CounselingHearing Loss, SensorineuralHumansMaleMembrane ProteinsNails, MalformedPedigreePeroxisomal DisordersPhenotypeRetinal DegenerationATPases Associated with Diverse Cellular ActivitiesMembrane ProteinsPEX1 protein, humanPEX6 protein, humanamelogenesis imperfectheimler syndromeperoxisomal disordersretinal degenerationsensorineural hearing loss

Identifiers

PMID32866347
PMCPMC8117942
OpenAlexW3082285348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.